Clinical Trial

Real World Asparaginase Therapy Toxicity

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This research study is being done to learn more about the short term and long term side effects of treatment with asparaginase drugs, which are commonly used in acute lymphoblastic leukemia (ALL) or acute lymphoblastic lymphoma (LLy) therapy.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2025-05-28; most recent amendment 2026-06-29.
Trial Details
NCT Number NCT07008027
Lead Sponsor St. Jude Children's Research Hospital
Conditions Drug Toxicity
Enrollment 200 participants
Start Date 2026-09
Primary Completion 2030-07 (estimated)
Study Completion 2031-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-13